Canada Life
AZN icon

Canada Life’s AstraZeneca AZN Stock Holding History

Canada Life’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285M Buy
1,526,363
+4,497
+0.3% +$846K 0.45% 37
2026
Q1 		$296M Buy
1,521,866
+1,520,623
+122,335% +$293M 0.53% 30
2025
Q4 		$229K Buy
1,243
+634
+104% +$111K ﹤0.01% 1603
2025
Q3 		$90K Buy
609
+118
+24% +$17.9K ﹤0.01% 1774
2025
Q2 		$69K Buy
491
+38
+8% +$5.33K ﹤0.01% 1808
2025
Q1 		$67K Buy
453
+82
+22% +$11.9K ﹤0.01% 1830
2024
Q4 		$49K Sell
371
-153
-29% -$21.4K ﹤0.01% 1893
2024
Q3 		$82K Buy
524
+129
+33% +$20.8K ﹤0.01% 1890
2024
Q2 		$62K Buy
395
+142
+56% +$21.4K ﹤0.01% 1946
2024
Q1 		$34K Buy
253
+73
+41% +$9.67K ﹤0.01% 2047
2023
Q4 		$24K Sell
180
-350
-66% -$45.5K ﹤0.01% 2085
2023
Q3 		$72K Buy
530
+265
+100% +$36.2K ﹤0.01% 2027
2023
Q2 		$38K Sell
265
-910
-77% -$134K ﹤0.01% 2034
2023
Q1 		$163K Buy
1,175
+479
+69% +$64.4K ﹤0.01% 1899
2022
Q4 		$94K Buy
696
+174
+33% +$21.8K ﹤0.01% 1997
2022
Q3 		$57K Buy
522
+134
+35% +$17K ﹤0.01% 2076
2022
Q2 		$51K Buy
388
+125
+48% +$16.4K ﹤0.01% 2055
2022
Q1 		$36K Buy
263
+133
+102% +$15.9K ﹤0.01% 2234
2021
Q4 		$15K Sell
130
-168,099
-100% -$19.8M ﹤0.01% 2416
2021
Q3 		$20.3M Buy
+168,229
New +$19.6M 0.05% 393
2017
Q4 		– Sell
-158,376
Closed -$10.7M – 2548
2017
Q3 		$10.7M Buy
+158,376
New +$10M 0.03% 502
2015
Q3 		– Sell
-17,436
Closed -$1.11M – 2450
2015
Q2 		$1.11M Buy
17,436
+8
+0% +$548 ﹤0.01% 903
2015
Q1 		$1.19M Sell
17,428
-237
-1% -$16.5K ﹤0.01% 889
2014
Q4 		$1.25M Buy
17,665
+4,300
+32% +$308K ﹤0.01% 870
2014
Q3 		$955K Buy
13,365
+5,300
+66% +$388K ﹤0.01% 896
2014
Q2 		$598K Hold
8,065
– – ﹤0.01% 902
2014
Q1 		$521K Buy
+8,065
New +$521K ﹤0.01% 906

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Canada Life's AZN Position: Q2 2026 in Review

Canada Life increased its AstraZeneca (AZN) stake by 0.3% in Q2 2026, buying an estimated $846K and bringing the position to 1,526,363 shares worth $285M. The position accounts for 0.45% of the portfolio, ranked #37.

Canada Life first reported a position in AZN in Q1 2014 and has held it in 27 quarters since. The position peaked at $296M in Q1 2026. 1,505 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Canada Life held 1,526,363 shares of AstraZeneca worth $285M as of Q2 2026.
  • Canada Life bought 4,497 AstraZeneca shares in Q2 2026, an estimated $846K.
  • AstraZeneca made up 0.45% of Canada Life's portfolio in Q2 2026, its #37 holding.
  • Canada Life first reported a position in AstraZeneca in Q1 2014 and has held it in 27 quarters since.
  • Canada Life's AstraZeneca position peaked at $296M in Q1 2026.
  • 1,505 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.